- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glimepiride (HOE490)
Total 306 results
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
Rehab WeridaCompletedDiabetes Mellitus, Type 2Egypt
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Haukeland University HospitalUnknownInsulin-dependent Diabetes Mellitus | Maturity-Onset Diabetes of the Young, Type 3 | Maturity Onset Diabetes of the Young, Type 1 | Childhood Diabetes MellitusNorway
-
Brigham and Women's HospitalCompleted
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
GRADE Study GroupBristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompletedType 2 Diabetes | Comparative Effectiveness of Glycemia-lowering MedicationsUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
Kyunghee University Medical CenterTakeda; Korea University Guro Hospital; Ajou University School of Medicine; Kangbuk... and other collaboratorsUnknownDiabetesKorea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
SanofiCompletedDiabetes Mellitus, Type 2Jordan
-
AstraZenecaCompleted
-
SanofiCompletedType 2 Diabetes MellitusCanada
-
Astellas Pharma IncCompleted
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Merck Sharp & Dohme LLCCompleted
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Vanderbilt UniversityCompleted
-
Yonsei UniversityNot yet recruitingDiabetes Mellitus | Sodium-Glucose Transporter 2 Inhibitors | Cellular SenescenceKorea, Republic of
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
Yonsei UniversityCompletedType2 Diabetes MellitusKorea, Republic of
-
Hannover Medical SchoolBoehringer IngelheimTerminated
-
SanofiCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimCompleted
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
University Hospital, Gentofte, CopenhagenNovo Nordisk A/S; University of CopenhagenCompletedMaturity-onset Diabetes of the YoungDenmark
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
SanofiCompletedType I Diabetes MellitusBrazil
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline BeechamCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
SanofiCompleted
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
SanofiCompleted
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
SanofiCompleted
-
SanofiActive, not recruiting
-
Gulf Regional Research & Educational Services, LLCUnknownMechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesDiabetes Mellitus Type 2United States
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
University of MichiganAstraZenecaCompletedCardiovascular Diseases | Type2 DiabetesUnited States
-
Novartis PharmaceuticalsCompletedType II Diabetes MellitusGermany